Insider trade

Nephros (NEPH): Director received 3,514 shares

Arthur H Amron, Director at Nephros, reported a grant / award of 3,514 shares.

3,514
Shares
Traded
Nov 9, 2026
Filed
Nov 12, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade. A share price line is a session where the close moved at least 10% and four times its usual daily change.

The company's last weighty Form 8-K report up to this date: reported its results, 95 days earlier (Aug 6, 2026). The first one after it: changed a top executive or board member, 1 day later (Nov 10, 2026).

  1. Company filing · Form 8-K · ResultsReported its results
  2. Share price · 3.55 → 3.02, about 4× a usual dayShare price fell 14.9% in one session

What came next

  1. Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 10, 2026, Lisa Nettis notified the Board of Directors (the “Board”) of Nephros, Inc. (the “Company”) of her resignation from the Board, effective on November 26, 2026.”
  2. 5% stakeTopline Capital Management, LLC reported a passive stake (13G) of 6.4%
  3. Insider · First insider buy since May 2024Director purchased ~$15K of NEPH shares in the open market
  4. InsiderDirector purchased ~$7.1K of NEPH shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Nephros

For Nephros, OQRO holds 2 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NEPH page.

Other recent filings by Arthur H Amron, Director

The full history of Arthur H Amron, Director is on the profile page.

How this filing works

Explore the data

Common questions

Which Nephros (NEPH) insider traded, and how much?

Arthur H Amron, Director at Nephros, reported a grant / award of 3,514 shares. Not an open-market trade.

When did it happen, and when was it made public?

Traded: Nov 9, 2026. Filed: Nov 12, 2026. That is 3 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Nephros recently?

For Nephros, OQRO holds 2 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the NEPH page.

Does this mean NEPH stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Nephros

Everything OQRO holds on this company is on its NEPH page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data